IMPORT / EXPORT NARCOTICS BY CARRYING

Similar documents
This form should be completed and sent to:

This form should be completed and sent to:

APPENDIX A FIRST SCHEDULE PSYCHOTROPIC SUBSTANCES

Key words: Mucocutaneous Lymph Node Syndrome, Incidence Rate, Geographical Distribution, Temporal Distribution, Japan. METHODS

Z-drugs and risk of falls and fractures: A systematic review and metaanalysis

1. Carrying Personal Medications into Thailand A. Medications containing narcotic drugs of category 2

The International Drug Control Conventions Schedules of the Convention on Psychotropic Substances of 1971, as at 25 September 2013

Tuberculosis Surveillance Center-RIT/JATA TUBERCULOSIS IN JAPAN

List of Psychotropic Substances under International Control

Study on Influence of Diabetes Mellitus for the Charged Cost and Length of Stay among the Angina Pectoris Patient in Japan

(The original text has been published in the Federal Law Gazette (Bundesgesetzblatt - BGBl.) I 2001, )

Japanese Encephalitis: Surveillance and Elimination Effort in Japan from 1982 to 2004

Study of Drug Adherence in a Large Japanese Population with Rheumatoid Arthritis: Epidemiological Survey Focused on District and Subject Ages

MINISTRY OF HEALTH. THE CRIM INAL JUSTICE (INTERNATIONAL SI. No. 110 of 2000 CO-OPERATION) ACT, (No.42 of 2000)

NOT FOR HUMAN CONSUMPTION

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

MINISTRY OFtlISAI,TH

Noncognitive Traits and Social Preferences Formulated by Elementary School Uniforms

Prevalence of molar incisor hypomineralization and regional differences throughout Japan

Int. J. Environ. Res. Public Health 2013, 10, ; doi: /ijerph

Dietary patterns among Japanese adults: findings from the National Health and Nutrition Survey, 2012

Relationships Between Percentage of Forest Coverage and Standardized Mortality Ratios (SMR) of Cancers in all Prefectures in Japan

List I. Narcotic drugs, psychotropic substances and precursors, turnover of which on the territory of Azerbaijan Republic is prohibited.

Part two Deuxième partie Segunda parte

Use of the Physiotherapy Evidence Database (PEDro) in Japan

Cancer burden in Japan based on the latest cancer statistics: need for evidence-based cancer control programs

Part two Deuxième partie Segunda parte

for those who are bringing medicines into Japan

Annual Dialysis Data Report 2014, JSDT Renal Data Registry (JRDR)

ドキュメントの表示. Q&A for those who bring medicines into Japan

substances provided for in Schedules I, II and III in the Annex, authorized for a single transport operation; f) transport operator the natural or

Severe Fever with Thrombocytopenia Syndrome (SFTS) viruses

Do The States Of The Union Have. Authority To Disregard. International Law As Established. By Treaties Entered Into By.

Q&A for those who bring medicines into Japan

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

1. Amphetamine (Adderall, desoxyn, Dexedrine,dextrostat, spancap, oxydess II)

LCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching

Rapid screening and semi-quantitative analysis for forensic drugs in blood using liquid chromatography triple quadrupole mass spectrometry

INTAKE OF NUTRITION ( )

An Overview of Regular Dialysis Treatment in Japan (as of 31 December 2012)

Oregon Health & Science University Department of Pathology, Division of Laboratory Medicine Core Laboratory

hypnotics and anxiolytics

DrugSmartCup & DrugSmartDip Accuracy Report as produced by Ameditech, Inc.

The Journal of Veterinary Medical Science

ToxCup Drug Screen Cup Step-by Step Instructions

Appendix 3: Taking controlled and prescription drugs to other countries

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.

Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT

List of narcotic substances circulation of which is restricted in Uzbekistan

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group.

Dengue Situation Update Number 450. Update on the dengue situation in the Western Pacific Region

Electrical & Chemical Signaling

Preface 2009 SPECIAL ARTICLE. Esophagus (2016) 13: DOI /s y

Rapid Drug Test Cup Step-by Step Instructions

Physician s Reference for Urine and Blood Drug Testing and Interpretation

Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature. Distributed to # of Copies Distributed to # of Copies

diazepam lorazepam converting converting Diazepam Valium Lorazepam Ativan lorazepam diazepam conversion Valium Lorazepam Ativan conversion lorazepam

DRUGS OF ABUSE TEST CUPS 14-DRUG PANEL WITH ADULTERANTS Step by Step Instructions

Offline and online sample extraction for the quantification of benzodiazepines in human plasma or serum for clinical research

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use

As Introduced. 132nd General Assembly Regular Session H. B. No Representative Ramos Cosponsors: Representatives Seitz, Fedor, Ashford

CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva)

What is CCC and Why is Japan leading the Trial?

Drugs of Abuse I Serum

A Rapid Method for Detection of Drugs of Abuse in Blood Samples Using the Thermal Separation Probe and the 5975T LTM GC/MS

Naoto INOUE, Kaori FUJITA, Zhongfa YANG, Masakazu KATO, Shu-hei UEHARA,

2017 Alberta Triplicate Prescription Program Atlas

Table 1. Frequency of resistant viruses isolated in Japan during 2007/2008 influenza season.

Have approved and decreed: Chapter 1 Definitions

PROGRAM FOR THE USE OF CONTROLLED SUBSTANCES OR PRECURSOR/LIST CHEMICALS IN RESEARCH

CNS DEPRESSANT OVERDOSE

Pharmacokinetics and Disposition of UDM Comparison of Various Sources for Drug Testing: Urine, Blood, Hair, Saliva. Edward J. Cone, Ph.D.

Population Attributable Fraction of Mortality Associated with Tobacco Smoking in Japan: A Pooled Analysis of Three Large-scale Cohort Studies

Country: Uzbekistan Date: Documentation required (i.e. issued/endorsed by medical practitioner or authorized health authority)

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY

An Overview of Regular Dialysis Treatment in Japan as of 31 December 2003

Clonazepam to lorazepam conversion

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY

Minister of Social Affairs. Passed No. 73 RTL 2005, 57, 807 Entry into force

National Inspection Checklist for Retail Pharmacies

Lorazepam iv to po conversion Hd.taarak.mehta.sex.phto aajka kalyan fix open your system is heavily damaged

Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS

Japan Trauma Data Bank Report 2013 ( )

Patient Instructions

Update on the dengue situation in the Western Pacific Region

Test Definition: PCDSO Pain Clinic Drug Screen, Urine

CHAPTER 206, Laws of 1981

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine

Forensic Toxicology Scope of Testing and Detection Limits

Welcome - SAMHSA s Role. Welcome SAMHSA Key Messages 4. Welcome SAMHSA s Direction

Prescription Refills during an Emergency

Ativan to klonopin conversion

Corporate Profile. Capabilities. Copyright CROee

DOF. Scheme Description. Drugs in Oral Fluid Scheme

Evaluation of an LC-MS/MS Research Method for the Analysis of 33 Benzodiazepines and their Metabolites

Epi Data Tables. Benzodiazepines in New York City. Data Tables

The Drug Testing Process. Employer or Practice

Urine Opioid Dependency Panel (UODP) 1

Transcription:

IMPORT / EXPORT NARCOTICS BY CARRYING Any person who intends to enter Japan carrying narcotics (example: morphine, codeine, oxycodone, pethidine, hydrocodone) for his / her own medical use is required to obtain an advance permission from the Director-General of one of the eight Regional Bureaus of Health and Welfare, JAPAN based on the"narcotics and Psychotropics Control Law". Narcotics can not be imported / exported for treatment of the addiction. Described below are the necessary procedures for obtaining an advance permission from the Director-General, Regional Bureau of Health and Welfare, JAPAN to enter / leave Japan carrying narcotics for his / her medical use. 1 Procedures: The following documents should be submitted to Narcotics Control Department of one of the eight Regional Bureaus of Health and Welfare in advance (see attached). 2 Required documents: 1) Application form (see appendix) When the re-import (re-export) of the narcotics are foreseen, separate application forms for the import (required for entering Japan carrying narcotics) and for the export (required for departing Japan carrying narcotics) should be submitted together. The estimated quantity of narcotics remaining at the point of departure should be indicated in the application form for the re-export. 2) Medical certificate A medical certificate by his / her doctor identifying the disease, the necessity of narcotics for his / her treatment, the names of narcotics and their quantities prescribed should be submitted together with the application forms. 3 Two weeks is necessary to process the application. In case of urgency, please send by fax the application forms with medical certificate at least two weeks before your arrival / departure in / from Japan. (The original forms should still be sent by air-mail.)

APPLICATION FORM (IMPORT) This format to be used in applying for permission to import narcotics by carrying. Name of narcotics Quantity Narcotics to be imported by carrying Reason for the entry into Japan Reason for the necessity for narcotics use Time of entry into Japan Name of port of entry As stated above, I hereby apply for permission to import narcotics by carrying. Date: Address: Phone: E-mail: Name: Fax: Signature: To: Director-General Regional Bureau of Health and Welfare This form should be typed or printed. Separate application forms for each Import and Export of narcotics are required.

APPLICATION FORM (EXPORT) This format to be used in applying for permission to export narcotics by carrying. Name of narcotics Quantity Narcotics to be exported by carrying Reason for departure from Japan Reason for the necessity for narcotics use Time of departure from Japan Name of port of departure As stated above, I hereby apply for permission to export narcotics by carrying. Date: Address: Phone: E-mail: Name: Fax: Signature: To: Director-General Regional Bureau of Health and Welfare This form should be typed or printed. Separate application forms for each Import and Export of narcotics are required.

SAMPLE (1) APPLICATION FORM (IMPORT) This format to be used in applying for permission to import narcotics by carrying. Name of narcotics Quantity Narcotics to be 10mg 10 tabs. imported by carrying (Morphine sulfate) (100mg) 5 mg (Oxycodone hydrochloride) 20 packs (100 mg) Reason for the entry into Japan To attend the International Conference of ABC Reason for the To alleviate pain associated with necessity for narcotics the medical condition use Time of entry into 20 February 2001 Japan Name of port of entry Narita International Airport As stated above, I hereby apply for permission to import narcotics by carrying. Date: 20 January 2001 Address: A-123, Washington, St. New York U.S.A. Phone: 1-123-456-7890 Fax: 1-123-456-9999 E-mail: abcde@fg.hi Name: Sherlock Holmes Signature: To: Director-General Kanto-Shin'etsu Regional Bureau of Health and Welfare This form should be typed or printed. Separate application forms for each Import and Export of narcotics are required.

SAMPLE (2) APPLICATION FORM (EXPORT) This format to be used in applying for permission to export narcotics by carrying. Name of narcotics Quantity Narcotics to be 10mg 10 tabs or less exported by carrying (Morphine sulfate) (100mg or less) 5 mg (Oxycodone hydrochloride) 20 packs or less (100mg or less) Reason for departure from Japan To return to my country Reason for the To alleviate pain associated with necessity for narcotics the medical condition use Time of departure 25 February 2001 from Japan Name of port of departure Narita International Airport As stated above, I hereby apply for permission to export narcotics by carrying. Date: 20 January 2001 Address: A-123, Washington, St. New York U.S.A. Phone: 1-123-456-7890 Fax: 1-123-456-9999 E-mail: abcde@fg.hi Name: Sherlock Holmes Signature: To: Director-General Kanto-Shin'etsu Regional Bureau of Health and Welfare This form should be typed or printed. Separate application forms for each Import and Export of narcotics are required.

IMPORT / EXPORT PSYCHOTROPICS BY CARRYING Procedures for Import / Export of psychotropics by carrying 1) The psychotropics listed in the following Table can be imported / exported. If you intend to import / export the psychotropics equal to or less than the amount indicated in the Table (excluding injection form), you don't need a certificate written by your doctor nor the permission by authorities under the "Narcotics and Psychotropics Control Law". 2) If you intend to import / export the psychotropics more than the amount indicated in the Table or those in injection form, you should have a certificate written by your doctor identifying the disease, the necessity of the drug (psychotropics) for your treatment, the names of psychotrpics and their quantities prescribed. Table (List of Psychotropics) Schedule I Schedule III Zipeprol 9 g Triazolam 15 mg Secobarbital 6 g Nitrazepam 450 mg Fenetylline 3 g Nimetazepam 150 mg Phenmetrazine 2.25 g Nordazepam 450 mg Mecloqualone 9 g Halazepam 4.8 g Methylphenidate 2.16 g Barbital 18 g Modafinil 6 g Haloxazolam 300 mg Schedule II Pinazepam 600 mg Amobarbital 9 g Vinylbital 4.5 g Cathine 1.5 g Pipradrol 180 mg Glutethimide 15 g Pyrovalerone 2.4 g Cyclobarbital 6.75 g Phenazepam 300 mg Flunitrazepam 60 mg Phenobarbital 6 g Butalbital 4.5 g Fencamfamine 1.8 g Buprenorphine 80 mg Phendimetrazine 3.15 g Pentazocine 18 g Phentermine 1.125 g Pentobarbital 4.5 g Fenproporex 360 mg Butobarbital 6 g Schedule III Prazepam 600 mg Alprazolam 72 mg Fludiazepam 22.5 mg Aminorex 300 mg Flurazepam 900 mg Allobarbital 3 g Propylhexedrine 2.25 g Amfepramone 2.25 g Brotizolam 15 mg

Ethchlorvynol 22.5 g Bromazepam 450 mg Estazolam 120 mg Pemoline 6 g Etizolam 90 mg Benzfetamine 1.5 g Ethinamate 30 g Mazindol 90 mg Etilamfetamine 1.8 g Midazolam 450 mg Oxazepam 2.7 g Mesocarb 900 mg Oxazolam 1.8 g Medazepam 900 mg Camazepam 1.8 g Methyprylon 12 g Quazepam 900 mg Methylphenobarbital 12 g Cloxazolam 360 mg Mefenorex 1.41 g Clotiazepam 900 mg Meprobamate 18 g Clonazepam 180 mg Lefetamine 3 g Clobazam 2.4 g Ethyl loflazepate 60 mg Clorazepate 900 mg Loprazolam 60 mg Chlordiazepoxide 1.8 g Lorazepam 90 mg Ketazolam 1.8 g Lormetazepam 60 mg Diazepam 1.2 g Secbutabarbital 3.6 g Zopiclone 300 mg Zolpidem 300 mg Tetrazepam 12 g Temazepam 900 mg Delorazepam 180 mg

IMPORT / EXPORT OTHER DRUGS BY CARRING 1) Heroin, Opium powder, Methamphetamine / Amphetamine No person shall import or export heroin, opium powder, methamphetamine / amphetamine (including their pharmaceutical forms). 2) Cannabis No person shall import or export any forms of cannabis. 3) Stimulants raw materials No person shall import / export stimulant raw materials (such as ephedrine, pseudoephedrine, including their pharmaceutical forms). Import / Export for personal use, except for pharmaceuticals containing -no more than 10% of ephedrine or -no more than 10% of methylephedrine or -no more than 10% of phenylacetic acid or -no more than 50% of norephedrine(phenylpropanolamine) which can be imported / exported without permission from authorities under the "Stimulants Control Law".

List of Narcotics Control Department, Regional Bureau of Health and Welfare Name of Narcotics Location, Telephone, Facsimile Area in charge Control Department Narcotics Control 060-0808 Hokkaido Department, Hokkaido 1-1, Nishi 2 chome, Kita 8 jo, Kita-ku Regional Bureau of Sapporo-shi Health and Welfare tel:81-11-726-3131 fax:81-11-709-8063 Narcotics Control 980-0014 Aomori, Iwate, Department, Tohoku 2-23, Hon-cho 3 chome, Aoba-ku, Sendai-shi Miyagi, Akita Regional Bureau of Yamagata, Health and Welfare tel:81-22-221-3701 fax:81-22-221-3713 Fukushima Narcotics Control 102-8309 Ibaraki, Tochigi, Department, 2-1, kudanminami 1chome, chiyoda-ku, Gunma, Saitama, Kanto-Shin'etsu Tokyo-to Chiba, Tokyo, Regional Bureau of Kanagawa, Health and Welfare tel:81-3-3512-8691 fax:81-3-3512-8689 Yamanashi, Nagano, Niigata Narcotics Control 460-0001 Shizuoka, Aichi, Department, Tokai 5-1, Sannomaru 2 chome, Naka-ku, Mie, Gifu, Hokuriku Regional Nagoya-shi Toyama, Ishikawa Bureau of Health and Welfare tel:81-52-951-6911 fax:81-52-951-6876 Narcotics Control 540-0008 Fukui, Shiga, Department, Kinki 1-76, Otemae 4 chome, Chuo-ku, Osaka-shi Kyoto, Osaka, Regional Bureau of Hyogo, Nara, Health and Welfare tel:81-6-6949-6336 fax:81-6-6949-6339 Wakayama Narcotics Control 730-0012 Tottori, Department, 6-30, Kami-Hacchobori, Naka-ku, Shimane, Chugoku-Shikoku Hiroshima-shi Okayama, Regional Bureau of Hiroshima, Health and Welfare tel:81-82-227-9011 fax:81-82-227-9174 Yamaguchi Narcotics Control 760-0019 Tokushima, Department, Shikoku 3-33, sunport, Takamatsu-shi Kagawa, Regional Bureau of Ehime, Kouchi Health and Welfare tel:81-87-811-8910 fax:81-87-823-8810 Narcotics Control 812-0013 Fukuoka, Saga, Department, Kyushu 10-7, Hakataeki Higashi 2 chome Nagasaki, Regional Bureau of Hakata-ku, Fukuoka-shi Kumamoto, Health and Welfare Oita, Miyazaki tel:81-92-472-2331 fax:81-92-451-4539 Kagoshima, Okinawa Your application should be submitted to the Narcotics Control Department mentioned above.

1 In case you will enter Japan; To the Narcotics Control Department in charge of the area where you will enter into Japan. 2 In case you are hospitalized in Japan; To the Narcotics Control Department in charge of the area where the hospital is located. 3 In case you live in Japan; To the Narcotics Control Department in charge of the area where your domicile is located.